In-Office Amoxicillin to Increase Graded-Dose Challenges at Initial Evaluation for Penicillin Allergy
The Journal of Allergy and Clinical Immunology: In Practice · 2023
DOI: 10.1016/j.jaip.2023.04.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2023. Verfasst von Margaret Redmond und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy and Immunology, Nationwide Children's Hospital, Columbus, Ohio. Electronic address: Margaret.redmond@nationwidechildrens.org. Hauptthemen laut MEDLINE: Drug Hypersensitivity, Hypersensitivity. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: More than 90% of pediatric patients labeled with a penicillin allergy can tolerate subsequent treatment courses without reaction. Graded-dose challenges (GDCs) are an important tool to clarify reported penicillin allergy. OBJECTIVE: To increase the use of same-day amoxicillin GDCs among patients with a low-risk penicillin allergy history who presented for outpatient allergy office evaluation from 2% to 15% and sustain for 6 months. METHODS: New patients evaluated in an academic pediatric allergy clinic with a documented penicillin allergy were included, regardless of reason for referral. The percentage of these patients who were administered a GDC to amoxicillin at the initial evaluation was assessed over time. Multiple interventions were implemented to increase same-day GDC: amoxicillin, previously only available from pharmacy, was made available in clinic, and penicillin-allergic patients were scheduled earlier in the clinic session. RESULTS: The baseline rate of new patients with penicillin allergy who received a GDC increased from 2% to 18% after amoxicillin was stocked in the allergy clinic. GDCs further increased to 34% after penicillin-allergic patients were scheduled at a time conducive to challenge. CONCLUSIONS: Amoxicillin availability in the clinic setting increased the percentage of eligible patients who completed same-day GDCs. Scheduling adjustments further increased the ability to conduct GDCs. Proactive penicillin allergy delabeling efforts can be assisted through practical approaches in the outpatient setting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Allergy and Immunology, Nationwide Children's Hospital, Columbus, Ohio. Electronic address: Margaret.redmond@nationwidechildrens.org.
- Division of Allergy and Immunology, Nationwide Children's Hospital, Columbus, Ohio.
- Center for Clinical Excellence, Nationwide Children's Hospital, Columbus, Ohio.
- Department of Orthopedics, Nationwide Children's Hospital, Columbus, Ohio.
Zitieren
APA
Redmond, M., Scherzer, R., Hardy, C., Macias, C., Samora, J., & Stukus, D. (2023). In-Office Amoxicillin to Increase Graded-Dose Challenges at Initial Evaluation for Penicillin Allergy. The Journal of Allergy and Clinical Immunology: In Practice. https://doi.org/10.1016/j.jaip.2023.04.006
Vancouver
Redmond M, Scherzer R, Hardy C, Macias C, Samora J, Stukus D. In-Office Amoxicillin to Increase Graded-Dose Challenges at Initial Evaluation for Penicillin Allergy. The Journal of Allergy and Clinical Immunology: In Practice. 2023. doi:10.1016/j.jaip.2023.04.006
BibTeX
@article{Redmond2023,
author = {Redmond, Margaret and Scherzer, Rebecca and Hardy, Charles and Macias, Charlie and Samora, Julie and Stukus, David},
title = {In-Office Amoxicillin to Increase Graded-Dose Challenges at Initial Evaluation for Penicillin Allergy},
journal = {The Journal of Allergy and Clinical Immunology: In Practice},
year = {2023},
doi = {10.1016/j.jaip.2023.04.006}
}
EUVIMED